This month, the first series of clinical trials curated by the ISN-Advancing Clinical Trials (ISN-ACT) team will get us thinking about nephrology research and encourage more discussion about chronic kidney disease, dialysis and hypertension: from PD catheter exit site care, the effectiveness of Roxadustat, to the initial treatment of hypertension in Sub-Saharan Africans and...
This month, we have lots of new educational material for you to delve into. From new in-depth reviews in Kidney International (KI) to June's KI editor’s picks. Big science and big data in nephrology Over the next few months, Kidney International (KI) will feature in-depth reviews on big science, artificial intelligence, and machine learning. This review, the first in this series, provides...
Kidney International (KI) has published a paper, as a Supplement to its journal, focusing on increasing patient access to integrated end-stage kidney disease care (ESKD) and how this fits in with Universal Health Coverage . Authored by David Harris et al., the paper is entitled 'Increasing access to integrated ESKD care as part of Universal...
An executive summary of the 2018 KDIGO hepatitis C in CKD guideline: Welcoming advances in evaluation and management is now available in Kidney International. Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients with chronic kidney disease (CKD), including those on dialysis therapy and in those with a...
September's issue of Kidney international (KI) will feature an important article from Ziyad Al-Aly and colleagues, which uses Global Burden of Disease (GBD) data to show, in just one generation since 1990, an almost doubling of the incidence, prevalence and mortality of chronic kidney disease (CKD), and a more than 60% increase in disability-adjusted...
The 2017 impact factors have now been published. Find out more about how our publications have been rated! Kidney International’s (KI) 2017 Impact Factor has increased to 8.429 (a small increase over the 2016 IF of 8.395). Kidney International Supplements 2017 Impact Factor is 3.357 (a decrease from the 2016 IF of 5.593). KI ranks now...
Following March's second Global Kidney Health Summit in the United Arab Emirates, the outputs from this meeting are currently being written for publication. In the meantime, here is what came out the first Global Kidney Health Summit held in Canada in 2016. During the first ISN Global Kidney Health Summit, a selected group of 85 international key...
We sat down with Pierre Ronco to discover what lies ahead for one of nephrology’s leading journals and hear about his plans to respond to the challenges of publishing and education within the field. What do you enjoy the most about heading such a high-ranking journal? Pierre Ronco: ‘It is a privilege and a huge responsibility. Fortunately,...
The purpose of the Brief Report format is to publish concise but complete reports that present high-quality findings of exceptional interest, novelty, and broad significance for the readers of Kidney International. Manuscript considered as a potential Brief Report by the Editors will be sent to referees with a request of rapid review. If the manuscript...
We are excited to announce that Kidney International (KI) Reports has now been fully accepted and is live in PubMed Central (PMC). PMC indexed back to Volume 1, Issue 1 and there are 177 article records at present. We will feed new articles as they are published directly to PMC for indexing. KI Reports article records can...
